(1S)-1-[1,1'-biphenyl]-4-ylethan-1-amine
95%
- Product Code: 236842
CAS:
223418-63-1
Molecular Weight: | Molecular Formula: | ||
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, light-proof, inert gas |
Product Description:
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of drugs targeting central nervous system disorders. Its enantiomeric purity makes it valuable in asymmetric synthesis, where it helps induce desired stereochemistry in active pharmaceutical ingredients. Commonly employed in the preparation of beta-blockers and other cardiovascular agents due to its structural similarity to known bioactive molecules. Also utilized in research settings for the development of novel receptor ligands and enzyme inhibitors.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿23,810.00 |
+
-
|
250mg | 10-20 days | ฿32,180.00 |
+
-
|
(1S)-1-[1,1'-biphenyl]-4-ylethan-1-amine
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of drugs targeting central nervous system disorders. Its enantiomeric purity makes it valuable in asymmetric synthesis, where it helps induce desired stereochemistry in active pharmaceutical ingredients. Commonly employed in the preparation of beta-blockers and other cardiovascular agents due to its structural similarity to known bioactive molecules. Also utilized in research settings for the development of novel receptor ligands and enzyme inhibitors.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :